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Abstract
For satisfying the network trend and intelligent demand of biopharmaceutical, we proposed the energy optimization
consumption and management scheme of the drug green crowd data in the biological pharmaceutical cloud
environment. First, the biopharmaceutical process are mapped to the cloud platform, which can not only adapt to the
revolutionary changes in the way of biopharmaceutical research and but also build a network management platform
for pharmaceutical research and development. Secondly, based on the green crowd, we reconstruct the organization
structure of the cloud platform, production process, and value chain-driven portfolio, etc. Then, we divide the core of
the cloud platform architecture into five substages. The green screening, reorganization, and crowd data processing
will be completed by the cooperation of these stages. Finally, the drug green crowd architecture is embedded into the
time domain conversion interface and the state transition interface. In addition, the state energy consumption model
of the biological pharmaceutical cloud platform is constructed. The experimental results show that compared with the
traditional task-driven energy consumption management mechanism, the proposed management mechanism can
ensure higher throughput, higher effective flow rate, and higher effective energy consumption ratio.
Keywords: Biological pharmaceutical cloud environment, Drug green, Crowd data, Energy consumption, Optimization
management
1 Introduction
With the rapid development of computer network and
parallel computing [1], how to apply them to the bio-
pharmaceutical industry [2, 3] has become a research
focus in improving the production efficiency of the bio-
pharmaceutical industry [4] and reducing the cost of re-
search and development. The authors of article [5]
described a cloud-based workflow for genome annota-
tion processing that is underpinned by MeDICi—a
middleware designed for data-intensive scientific appli-
cations. The novel visualizations were proposed in article
[6] to facilitate manual gating. This method views a sin-
gle data of one biological sample as a high-dimensional
point cloud. The novel cloud-based medicine recom-
mendation was proposed by Zhang Y et.al [7], which can
recommend users with top-N related medicines accord-
ing to symptoms. Hans A et.al [8] studied the various
biomedical services that have been provided on cloud
and made a comparative study of these cloud-based bio-
medical services. The novel method for optimizing the
energy consumption of robotic manufacturing systems
was proposed in [9], which embedded detailed evalua-
tions of robots’ energy consumptions into a scheduling
model of the overall system. Li M et.al [10] proposed a
new multi-hop cognitive cellular network architecture to
facilitate the ever exploding data transmissions in cellu-
lar networks. A novel power optimization utility soft-
ware was proposed by Hazel T et.al [11], which
considered the different energy costs across the pipeline
pump/compressor stations, utility contracts, and pump/
compressor efficiency. The analytical framework for the
total energy consumption of an amplify-and-forward
multi-hop network was proposed in article [12] by
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employing M-ary quadrature amplitude modulation,
which can satisfy the average bit error rate requirement
at the destination over Rayleigh fading channels.
The article [13] investigated the possibility of using a
new Smart-ECO model, consisting of a smart device, in
order to optimize the electricity consumption per appli-
ance. A method of production scheduling oriented to
energy consumption optimization for process industry
was proposed in article [14], which is based on self-
adaptive differential evolution algorithm. The authors of
article [15] designed a workload model and a memory
energy consumption model based on software-defined
networking architecture. In article [16], the optimization
of energy consumption and environmental impacts of
chickpea production was conducted using data envelop-
ment analysis and multi-objective genetic algorithm
techniques.
Based on these findings, we proposed the energy con-
sumption optimization management mechanism with
drug green crowd data for biological pharmaceutical
cloud environment. The rest of the paper is organized as
follows. Section 2 describes the pharmaceutical green
crowd architecture in the cloud environment of bio-
logical medicine. Section 3 proposes the energy con-
sumption optimization management mechanism of drug
green crowd data. The performance evaluation is shown
in Section 4. Finally, Section 5 concludes the paper.
2 Pharmaceutical green crowd architecture in the
cloud environment of biological medicine
2.1 Biopharmaceutical cloud platform
It is difficult to find new chemical entities in biological
pharmacy. This issue extended the research and devel-
opment time of new drugs and increased the research
and development (R & D) costs. At the same time, the
interference of external environmental factors and the
variability of the biological pharmaceutical platform can-
not be predicted. Therefore, compared with the trad-
itional biological pharmaceutical technology, the recent
pharmaceutical research and development of the
pharmaceutical industry tends to be networked and in-
telligent. The network of biopharmaceutical [17] was
reflected in the revolutionary changes and the network
management way of biological research and pharmaceut-
ical research and development. Intelligent [18] includes
pharmaceutical platform organization structure, produc-
tion process, and value chain-driven combination and
other aspects of the intelligent level.
In order to give full play to the network and
intelligence of the driving force of biopharmaceutical,
the biopharmaceutical platform is gradually changing.
On the one hand, in order to reduce R & D costs,
shorten the development cycle, and decentralize R & D
risk, the independent laboratory model gradually trans-
ferred to the direction of cooperation in R & D [19]. On
the other hand, the application of a large number of new
technologies and methods would provide a comprehen-
sive [20] experimental platform. This platform can ef-
fectively shorten the time of drug development and
improve the range of drug types.
The cloud platform has the advantages of the above
two aspects. The combination of biopharmaceutical and
cloud platform can not only build the cloud scale of bio-
pharmaceutical research and development platform but
also provide a comprehensive interactive platform for
drug experiment.
Biopharmaceutical cloud platform is a very complex
cloud environment. The cloud environment is involved
in different aspects of biological pharmaceuticals, as
shown in Fig. 1. Specific contents are as follows:
Fig. 1 Biopharmaceutical cloud platform
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(1)Biological pharmaceutical technology with high
difficulty and complexity.
(2)Experimental platform of biopharmaceutical
technology
(3)The intelligent management of biological
pharmaceutical cloud platform
(4)Cloud platform for the virtual environment of
various diseases of experimental drug performance,
such as cancer, genetic disease, cardiovascular
disease, infection, and immunity.
(5)Network cloud platform for all kinds of drugs and
pharmaceutical process. The adaptability of the
biological pharmaceutical cloud platform can be















Here, EN said network cloud adaptation. EM denotes
smart cloud adaptation. B represents the fitness of bio-
pharmaceutical technology. C represents the fitness of
the drug experimental platform. Parameter n represents
the number of test objects on the platform. IC indicates
intelligent cloud weight. V represents the balance of
cloud platforms. Parameter m says share of biotech
drugs.
2.2 Drug green crowd architecture
There are P servers in the biopharmaceutical cloud plat-
form. Biopharmaceutical networking requires f virtual
clouds with high frequency and large memory. The
cloud platform centric server can support L data link
with parallel transmission. The intelligent model of
cloud platform center can satisfy the K biopharmaceut-
ical process in parallel. All biopharmaceutical industry
processes are in the same network environment and
cloud environment.
Drug performance vector PB = (PB0, PB1, …, PBn-1).
We need to design n virtual test cloud environments
that must satisfy the requirements of drug performance
testing. The real-time available memory resources and
processor utilization of the cloud platform server can be
obtained by Eq. (2). From Eq. (2), the more the parallel
data link, the lower the utilization rate is. It is difficult to














Here, IM is used to show the memory utilization. D
represents the data size of each data link. δ denotes data
link data utilization. ε represents the mutual interference
of parallel data chains. RCPU indicates processor
utilization. U represents the efficiency of the use of each
test server.
So, we proposed the green crowd architecture based
on the green drive of drug production, as shown in Fig. 2.
Here, the medicine green crowd module has five sub-
steps, which are S1, S2, S3, S4, and S5. The data of phar-
maceuticals was sent to S1. The session of
pharmaceuticals was sent to S2 and forwarded to S4.
The evaluation of pharmaceuticals was sent to S3 and
forwarded to S5. The final results of medicine green
crowd module were sent to the crowd cloud.
Fig. 2 Architecture of medicine green crowd module
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The architecture core in Fig. 2 is divided into five
stages. According to Eq. (3), stages S1, S2, and S4
complete the green screening and reorganization. Ac-
cording to Eq. (4), stages S3 and S5 complete the crowd
data processing.












Here, Dg represents the data sequence of the
reorganization. ΔD is the mean value of data sequence
after green filter.















Here, DC expressed crowd data sequence. Parameter E
expresses crowd computation overhead. Parameter a
represents the length of the vector for the performance
evaluation of the drug. Parameter P represents a vector
of drug performance evaluation.
3 Energy consumption optimization management
mechanism of drug green crowd data
Biopharmaceutical cloud platform and drug green crowd
data processing is a complex organic system composed
of a number of dynamic regulatory modules. The mod-
ule of the system has a number of life cycle states. Each
life cycle state generates the corresponding energy con-
sumption. The energy consumption of the power condi-
tioning module can be divided into five basic stages:
initialization, green filtering, networking, crowd recon-
struction, and data processing.
The process of crowd data processing can be divided
according to the characteristics of biological pharma-
ceutical cloud platform. Energy consumption and per-
formance characteristics under different conditions are
as follows:
(1)Energy consumption of data processing state will be
the highest. The state is the interface between the
cloud platform and the outside world.
(2)The lowest energy consumption are the initialization
state and networking state. These states are used to
realize the network of biological pharmacy. The
energy consumption of green filter state is between
initialization state and reconstruction crowd state,
which is used to provide the raw data for the crowd
data processing. Conversion between the various
states requires time and energy consumption. The
transition between the green filter state and the
reconstruction crowd state is a linear time domain,
which is the minimum energy consumption of linear
transformation. Different states can be converted to
each other through the conversion interface. State
transition energy consumption is negligible. The
conversion of nonlinear conversion between
different states is converted to linear time domain
via conversion interface. The state energy
consumption model of biopharmaceutical cloud
platform is shown in Fig. 3. There are five states in
biopharmaceutical cloud platform, which are
initialization, green filter, crowd reconstruction,
networking, and data processing. The numbers of
arrows express the state transition priority. Time
domain conversion interface and state transition
interface as shown in Fig. 4. Here, the data was sent
by the sender and forwarded from α and β to
destination through the state interfaces, which
include the filter and crowd model.
The energy consumption optimization of the green
crowd data would be completed according to Eq. (5).







Here, the curve integral is used to optimize the energy
consumption of the biopharmaceutical cloud platform
and the drug green crowd data processing.
4 Performance verification of energy consumption
optimization management algorithm
Aiming at the biopharmaceutical cloud platform, the ex-
periment focuses on the energy consumption optimization
management mechanism of the medicine green crowd
data and the comparison between the performance of the
proposed energy consumption optimization management
mechanism based on drug green crowd data in the bio-
logical pharmaceutical cloud environment denoted as
ECO-DGC and task-driven energy consumption manage-
ment strategy denoted as TDE-MS. The task-driven en-
ergy management strategy drives the energy management
of cloud platform by using a concurrent task of the cloud
platform. In order to deeply evaluate the energy
optimization consumption performance of the proposed
optimization strategy, we used the effective flow ratio, sys-
tem throughput, and system evaluation metrics and com-
pared with the task-driven energy management strategy.
The configuration of the server configuration used by
the biopharmaceutical cloud platform is as shown in
Table 1. In the server, the memory data access is based
on the traditional memory architecture of the crowd
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data access operation delay. Internal bus energy con-
sumption and external communication serial port bus
energy consumption is related to time domain.
Figure 5 shows the effective flow comparison of
the cloud platform. The effective flow ratio of the
proposed scheme in large memory (512 MB) is
significantly higher than that of the task-driven scheme.
With the increased number of concurrent tasks,
most of the traffic flow in the task-driven scheme is
in the failure state, and the resource utilization rate
of the cloud platform is severely reduced. As a re-
sult, the system throughput rate of the proposed
scheme is better than that of the task-driven scheme.
In addition, the task-driven scheme, even if it is a
Fig. 4 Conversion interface
Fig. 3 State of energy consumption model of the biopharmaceutical cloud platform
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high throughput rate, the effective flow ratio is low,
so there is serious waste of system energy (See
Fig. 6). In the biopharmaceutical cloud platform, the
proposed scheme is deployed on P servers. Bio-
pharmaceutical network is equipped with the f vir-
tual cloud with high frequency and large memory.
The cloud platform center server can support the L
data link parallel transmission. The intelligent model
of cloud platform center can satisfy the K bio-
pharmaceutical process in parallel. All biopharma-
ceutical industry processes are in the same network
and cloud environment.
Figure 7 illustrates the total cloud platform energy
consumption of the two schemes. The proposed scheme
can improve the performance of the system while saving
energy consumption more than the task-driven energy
consumption management strategy. Along with the in-
crease of the memory space and the green crowd data,
the energy-saving effect is more and more obvious. The
energy-saving effect of the task-driven energy manage-
ment program is very poor for large memory space. The
proposed scheme is based on the power regulation of
the drug green crowd data. The energy consumption of
each module is divided into five stages: initialization,
green filtering, networking, crowd reconstruction, and
data processing. The process of crowd data processing
can be divided into different progress according to the
characteristics of biological pharmaceutical cloud plat-
form. Such partitioning and segmentation are more suit-
able for large memory space and large data.
5 Conclusions
In order to shorten the development cycle and reduce
the cost of pharmaceutical industry, we proposed the en-
ergy consumption optimization management mechanism
of the medicine green crowd data in the biological
pharmaceutical cloud environment. In order to shorten
the development cycle and reduce the cost of pharma-
ceutical industry, we proposed the energy consumption
optimization management mechanism of the medicine
green crowd data in the biological pharmaceutical cloud
environment. On the one hand, the cloud platform was
proposed to satisfy the revolutionary changes in the way
Table 1 Settings of servers
Parameters Value
Number of CPU 2*2
Memory data access delay 95*5 ns
Internal bus energy consumption with linear 0.165J
Internal bus energy consumption with nonlinear 0.967J
External communication serial bus energy consumption
with linear
0.564J
External communication serial bus energy consumption
with nonlinear
1.648J
Fig. 5 Effective flow ratio
Fig. 6 System throughput rate
Fig. 7 System effective energy consumption ratio
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of biological and pharmaceutical research and develop-
ment mode of network management requirements. Bio-
pharmaceutical are mapped to the cloud platform, which
include the definition of the organizational structure of
the cloud platform, production process, and value chain-
driven portfolio, etc. On the other hand, the cloud plat-
form architecture core is divided into five stages. Green
screening, reorganization, and crowd data processing
were completed. We proposed the drug green crowd
architecture based on the green drive of drug produc-
tion. Finally, the state energy consumption model of bio-
pharmaceutical cloud platform is constructed based on
the time domain interface and the state transition inter-
face. After many experiments and statistics, we found
that the proposed management strategy can solve the
management problem of the throughput, flow rate, and
energy consumption of different memory spaces and dif-
ferent data scales.
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